Tag: Amgen

Amgen has delivered a standout quarterly performance that has captured significant market attention. The biotechnology leader not only surpassed investor ...

Biotechnology leader Amgen finds itself at a critical juncture as Tuesday's quarterly earnings release approaches, with market participants closely monitoring ...

Biotechnology leader Amgen finds itself at a critical juncture. The company recently secured a major legal victory that clears a ...

The investment community is closely monitoring Amgen as a pivotal regulatory decision approaches that could significantly impact the company's growth ...

The biotechnology leader Amgen presents investors with a puzzling scenario. Despite announcing substantial capital investments and reporting robust quarterly earnings, ...

Amgen Inc. shares could be poised for a significant sentiment shift following two strategically important announcements from the biotechnology giant. ...

The biotechnology giant Amgen finds itself navigating a complex landscape where groundbreaking innovation collides with mounting competitive pressures. While the ...

Amgen Inc. finds itself navigating a complex landscape of significant opportunity and intensifying market pressures. The biotechnology giant has recently ...

Amgen reported stellar quarterly results, with revenue surging 9% to $9.2 billion—exceeding analyst expectations—and adjusted earnings per share jumping 21% ...